Visiongain has published a new report on Vitamin D Therapy Market Report 2021-2031: Forecasts by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Functional Food & Beverage, Pharma, Feed, and Personal Care), End User (Children, Adult, and Pregnant Women), IU Strength. PLUS, Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS, COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/vitamin-d-therapy-market-2021/#download_sampe_div
Vitamin D is considered to be a group of fat soluble vitamin that helps in increasing the intestinal absorption of calcium, phosphate and magnesium. The major vitamin D compounds in humans include D3 and vitamin D2. Vitamin D deficiency is one of the common problems among the people due to less exposure to symptoms of Vitamin D deficiency is muscle weakness and bone pain.
Vitamin D helps calcium absorption in the stomach and retains adequate serum calcium and phosphate absorptions to aid normal bone mineralization and to prevent hypercalcaemic tetany (involuntary contraction of muscles, leading to cramps and spasms). It is also needed for bone growth and bone remodelling by osteoblasts and osteoclasts [1-3]. Without sufficient vitamin D, bones can become thin, brittle, or deformed.
COVID-19 Impact on Vitamin D Therapy Market
The market is growing in this pandemic of COVID19 due to awareness of the healthcare segment among the masses. In this time period many programs are held by certain organisations regarding self-care oh health. People are getting aware of certain health care. Hence this market is expected to grow in future periods.
Market Drivers
The global Vitamin D Therapy market is driven by the factors such as increase in the target patient population, rise in awareness about vitamin D deficiency, surge in levels of malnutrition, increase in patient compliance to oral medication, rise in prevalence of deficiency of Vitamin D, aging population, sedentary lifestyles and lack of exposure to sun.
Get Detailed TOC @ https://www.visiongain.com/report/vitamin-d-therapy-market-2021/#download_sampe_div
Market Opportunities
The opportunities of growth for the Vitamin D market are yet to be explored and the countries with high prevalence of undernutrition people can prove to be a growth prospect for the company’s manufacturing Vitamin D drugs and dosages.
Market Challenge
The fortification of foods, which are already rich in Vitamin D, are likely to pose a challenge to the growth of Vitamin D Therapy Market.
Competitive Landscape
Global Vitamin D Therapy Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. Major players profiled in the report, include: Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India).
Recent Developments:
- In 2018, GlaxoSmithKline PLC completed the acquisition of Novartis’ 36.5% stake in its Consumer Healthcare Joint Venture for USD 13 billion.
- In 2018, GlaxoSmithKline plc and Pfizer Inc. join forces to form a new world-leading consumer healthcare joint venture. The joint venture has played a vital role in the categories of pain relief, respiratory, vitamin and mineral supplements, digestive health, skin health, and therapeutic oral health.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Vitamin D Therapy market and leading companies. You will find data, trends and predictions.
Find more Visiongain research reports on Therapeutic Drugs Sector click on the following links:
- Animal Vaccine Market
- Anticoagulants Market
- Antidiarrheal Drug Market
- Anti-acne Cosmetic Market
- Anti-neoplastic Agents Market
- Anti-snoring Treatment Market
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact:
Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.
